Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Wst-11
2. Wst11
3. Wst11 Compound
1. 759457-82-4
2. 457p824
| Molecular Weight | 840.3 g/mol |
|---|---|
| Molecular Formula | C37H43N5O9PdS |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 12 |
| Exact Mass | 839.18163 g/mol |
| Monoisotopic Mass | 839.18163 g/mol |
| Topological Polar Surface Area | 199 Ų |
| Heavy Atom Count | 53 |
| Formal Charge | 0 |
| Complexity | 1890 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Tookad is indicated as monotherapy for adult patients with previously untreated, unilateral, low risk, adenocarcinoma of the prostate with a life expectancy 10 years and:
- Clinical stage T1c or T2a;
- Gleason Score 6, based on high-resolution biopsy strategies;
- PSA 10 ng/mL;
- 3 positive cancer cores with a maximum cancer core length of 5 mm in any one core or 1-2 positive cancer cores with 50 % cancer involvement in any one core or a PSA density 0. 15 ng/mL/cm.
L01XD07
L - Antineoplastic and immunomodulating agents
L01 - Antineoplastic agents
L01X - Other antineoplastic agents
L01XD - Sensitizers used in photodynamic/radiation therapy
L01XD07 - Padeliporfin
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
49
PharmaCompass offers a list of Padeliporfin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Padeliporfin manufacturer or Padeliporfin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Padeliporfin manufacturer or Padeliporfin supplier.
PharmaCompass also assists you with knowing the Padeliporfin API Price utilized in the formulation of products. Padeliporfin API Price is not always fixed or binding as the Padeliporfin Price is obtained through a variety of data sources. The Padeliporfin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Padeliporfin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Padeliporfin, including repackagers and relabelers. The FDA regulates Padeliporfin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Padeliporfin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Padeliporfin supplier is an individual or a company that provides Padeliporfin active pharmaceutical ingredient (API) or Padeliporfin finished formulations upon request. The Padeliporfin suppliers may include Padeliporfin API manufacturers, exporters, distributors and traders.
Padeliporfin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Padeliporfin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Padeliporfin GMP manufacturer or Padeliporfin GMP API supplier for your needs.
A Padeliporfin CoA (Certificate of Analysis) is a formal document that attests to Padeliporfin's compliance with Padeliporfin specifications and serves as a tool for batch-level quality control.
Padeliporfin CoA mostly includes findings from lab analyses of a specific batch. For each Padeliporfin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Padeliporfin may be tested according to a variety of international standards, such as European Pharmacopoeia (Padeliporfin EP), Padeliporfin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Padeliporfin USP).
